Biblio

Export 623 results:
Author Title Type Year
Filters: Keyword is Alzheimer Disease  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Alzheimer Disease
K. Ishii, Yamada, T., Hanaoka, K., Kaida, H., Kojita, Y., Kono, A., Hanada, K., Saigoh, K., Sakuta, S., Hashimoto, M., Kato, T., and Nakamura, A., “Regional differences in glucose metabolic decline and tau deposition in the Alzheimer's continuum brain.”, J Alzheimers Dis, vol. 102, no. 1, pp. 228-236, 2024.
Z. Li, Fan, Z., and Zhang, Q., “The Associations of Phosphorylated Tau 181 and Tau 231 Levels in Plasma and Cerebrospinal Fluid with Cognitive Function in Alzheimer's Disease: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 98, no. 1, pp. 13-32, 2024.
L. A. Digma, Winer, J. R., and Greicius, M. D., “Substantial Doubt Remains about the Efficacy of Anti-Amyloid Antibodies.”, J Alzheimers Dis, vol. 97, no. 2, pp. 567-572, 2024.
M. Carpi, Fernandes, M., Mercuri, N. Biagio, and Liguori, C., “Sleep Biomarkers for Predicting Cognitive Decline and Alzheimer's Disease: A Systematic Review of Longitudinal Studies.”, J Alzheimers Dis, vol. 97, no. 1, pp. 121-143, 2024.
Y. Li, Chen, X., Zhou, M., Feng, S., Peng, X., and Wang, Y., “Microglial TLR4/NLRP3 Inflammasome Signaling in Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 1, pp. 75-88, 2024.
C. E. Johnson, Duncan, M. J., and M Murphy, P., “Sex and Sleep Disruption as Contributing Factors in Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 1, pp. 31-74, 2024.
R. Yan, Wang, W., Yang, W., Huang, M., and Xu, W., “Mitochondria-Related Candidate Genes and Diagnostic Model to Predict Late-Onset Alzheimer's Disease and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 99, no. s2, pp. S299-S315, 2024.
C. L. Greenblatt and Lathe, R., “Vaccines and Dementia: Part II. Efficacy of BCG and Other Vaccines Against Dementia.”, J Alzheimers Dis, vol. 98, no. 2, pp. 361-372, 2024.
B. Polis and Samson, A. O., “Addressing the Discrepancies Between Animal Models and Human Alzheimer's Disease Pathology: Implications for Translational Research.”, J Alzheimers Dis, vol. 98, no. 4, pp. 1199-1218, 2024.
H. Shimada, Doi, T., Tsutsumimoto, K., Makino, K., Harada, K., Tomida, K., and Arai, H., “Elevated Risk of Dementia Diagnosis in Older Adults with Low Frequencies and Durations of Social Conversation.”, J Alzheimers Dis, vol. 98, no. 2, pp. 659-669, 2024.
A. J. Espay, Herrup, K., Imbimbo, B. P., Kepp, K. P., and Daly, T., “Recalibrating the Risk-Benefit Profiles of Lecanemab and Donanemab: Scales, Immunoreactivity, and Changes in Amyloid-β42.”, J Alzheimers Dis, vol. 99, no. 3, pp. 877-881, 2024.
J. Valentin-Escalera, Leclerc, M., and Calon, F., “High-Fat Diets in Animal Models of Alzheimer's Disease: How Can Eating Too Much Fat Increase Alzheimer's Disease Risk?”, J Alzheimers Dis, vol. 97, no. 3, pp. 977-1005, 2024.
P. Y. Ng, Zhang, C., Li, H., and Baker, D. J., “Senescence Targeting Methods Impact Alzheimer's Disease Features in 3xTg Mice.”, J Alzheimers Dis, vol. 97, no. 4, pp. 1751-1763, 2024.
N. Vaishnav, Gonzalez, R., Karunungan, K., Tyler, A., Zheng, W., and Arias, J. J., “Creating an Unprotected Class: Addressing Legal Risks in the Era of Biologically-Defined Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 1, pp. 187-195, 2024.
A. M. R. McLaren and Kawaja, M. D., “Olfactory Dysfunction and Alzheimer's Disease: A Review.”, J Alzheimers Dis, vol. 99, no. 3, pp. 811-827, 2024.
D. Gohel, Zhang, P., Gupta, A. Kumar, Li, Y., Chiang, C. - W., Li, L., Hou, Y., Pieper, A. A., Cummings, J., and Cheng, F., “Sildenafil as a Candidate Drug for Alzheimer's Disease: Real-World Patient Data Observation and Mechanistic Observations from Patient-Induced Pluripotent Stem Cell-Derived Neurons.”, J Alzheimers Dis, vol. 98, no. 2, pp. 643-657, 2024.
C. E. Finch and Burstein, S. M., “Dementia in the Ancient Greco-Roman World Was Minimally Mentioned.”, J Alzheimers Dis, vol. 97, no. 4, pp. 1581-1588, 2024.
P. Du, Zhang, X., Lian, X., Holscher, C., and Xue, G., “O-GlcNAcylation and Its Roles in Neurodegenerative Diseases.”, J Alzheimers Dis, vol. 97, no. 3, pp. 1051-1068, 2024.
X. - X. Zhang, Wang, H. - R., Hu, Y. - Z., Sun, H. - M., Feng, Y. - X., and Jia, J. - J., “Association of Vitamin D Levels with Risk of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Prospective Studies.”, J Alzheimers Dis, vol. 98, no. 2, pp. 373-385, 2024.
J. Ren, Yu, Y., Wang, Y., Dong, Y., and Shen, X., “Association Between Urinary Glyphosate Exposure and Cognitive Impairment in Older Adults from NHANES 2013-2014.”, J Alzheimers Dis, vol. 97, no. 2, pp. 609-620, 2024.
W. B. Grant, “A Brief History of the Progress in Our Understanding of Genetics and Lifestyle, Especially Diet, in the Risk of Alzheimer's Disease.”, J Alzheimers Dis, vol. 100, no. s1, pp. S165-S178, 2024.
M. O. Etekochay, Amaravadhi, A. Rao, González, G. Villarrubi, Atanasov, A. G., Matin, M., Mofatteh, M., Steinbusch, H. Wilhelm, Tesfaye, T., and Praticò, D., “Unveiling New Strategies Facilitating the Implementation of Artificial Intelligence in Neuroimaging for the Early Detection of Alzheimer's Disease.”, J Alzheimers Dis, vol. 99, no. 1, pp. 1-20, 2024.
H. Stevens Smith, Robinson, J. O., Levchenko, A., Pereira, S., Pascual, B., Bradbury, K., Arbones, V., Fong, J., Shulman, J. M., McGuire, A. L., and Masdeu, J., “Research Participants' Perspectives on Precision Diagnostics for Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 3, pp. 1261-1274, 2024.
H. Takase, Hamanaka, G., Hoshino, T., Ohtomo, R., Guo, S., Mandeville, E. T., Lo, E. H., and Arai, K., “Transcriptomic Profiling Reveals Neuroinflammation in the Corpus Callosum of a Transgenic Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 3, pp. 1421-1433, 2024.
I. J. Sible and Nation, D. A., “Blood Pressure Variability and Plasma Alzheimer's Disease Biomarkers in the SPRINT Trial.”, J Alzheimers Dis, vol. 97, no. 4, pp. 1851-1860, 2024.

Pages